Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.53B |
| Enterprise Value | 7.03B |
| P/E Ratio | -11.91 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 9.62 |
| Price/Book Ratio | 1.17 |
| Enterprise/Revenue | 8.56 |
| Enterprise/EBITDA | 61.37 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.81 |
| Operating Margin | -0.73 |
AD
Management Effectiveness
| Return On Assets | -0.08 |
| Return On Equity | -0.09 |
Income Statement
| Revenue | 623.64M |
| Revenue/Share | 0.55 |
| Gross Profit | 387.56M |
| EBITDA | 164.13M |
| Net Income | -347.2M |
| Diluted EPS | -0.34 |
Balance Sheet
| Total Cash | 1.16B |
| Total Cash/Share | 1.07 |
| Total Debt | 17.89M |
| Total Debt/Equity | 0 |
| Current Ratio | 3.38 |
| Book Value Per Share | 4.74 |
Price History
| 52-Week Change | -22.19 |
| 52-Week High | 9.4 |
| 52-Week Low | 4.81 |
| Moving Average 50 Days | 6.3 |
| Moving Average 200 Days | 7.02 |
Statistics
| Average Volume | 64.75M |
| Shares Outstanding | 1.03B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.02 |
| Trailing Annual Dividend Yield | 0.36 |
| Payout Ratio | -0.04 |
| Last Split Factor | 3:2 |
| Last Split Date | July 04, 2019 |
AD
